Johannes Wesling Klinikum Minden

Initial and repeat reactions in the European Anaphylaxis Registry a comparative analysis (2022) Hoefer V, Doelle-Bierke S, Rueff F, Hartmann K, Pfoehler C, Treudler R, Wagner N, Worm M Conference contribution Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. (2022) Kuramatsu J, Gerner S, Ziai W, Bardutzky J, Sembill J, Sprügel M, Mrochen A, et al. Journal article Multiple tumorous lesions of the pituitary gland (2022) Von Schoening J, Flitsch J, Luedecke DK, Fahlbusch R, Buchfelder M, Buslei R, Knappe UJ, et al. Journal article Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma (2021) Christgen M, Kandt LD, Antonopoulos W, Bartels S, Van Bockstal MR, Bredt M, Brito MJ, et al. Journal article Use of biosimilars in the treatment of rheumatoid arthritis An overview (2021) Morf H, Witte T Journal article Patient-reported treatment satisfaction with Rivaroxaban in cancer patients with acute venous thromboembolism - Results from the CONKO-011 trial (2021) Sinn M, Juehling A, Hellmann M, Omar M, Suedhoff T, Stahl M, Krziwanie A, et al. Conference contribution A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2(-) Primary Breast Cancer (2020) Robertson JFR, Evans A, Henschen S, Kirwan CC, Jahan A, Kenny LM, Dixon JM, et al. Journal article Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts (2020) Garbe C, Keim U, Suciu S, Amaral T, Eigentler TK, Gesierich A, Hauschild A, et al. Journal article